Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

Nature

Volumn 424, Issue 6949, 2003, Pages 681-684

  Sullivan, Nancy J ^a   Geisbert, Thomas W ^b   Gelsbert, Joan B ^b   Xu, Ling ^a   Yang, Zhi Yong ^a   Roederer, Mario ^a   Koup, Richard A ^a   Jahrling, Peter B ^b   Nabel, Gary J ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; CONTAMINATION; DISEASES; DNA; IMMUNIZATION; VACCINES;

GLYCOPROTEINS (GP);

VIRUSES;

ADENOVIRUS VECTOR; DNA VACCINE; NUCLEOPROTEIN; VIRUS GLYCOPROTEIN;

MEDICINE; PRIMATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; EBOLA VIRUS; EXPRESSION VECTOR; IMMUNOPROPHYLAXIS; IMMUNOSTIMULATION; INFECTION PREVENTION; INFECTION RESISTANCE; MACACA; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; VACCINATION; VIRUS HEMORRHAGIC FEVER; VIRUS TRANSMISSION;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, VIRAL; CYTOKINES; EBOLAVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMORRHAGIC FEVER, EBOLA; IMMUNIZATION, SECONDARY; MACACA FASCICULARIS; MICE; TIME FACTORS; VACCINATION; VACCINES, DNA; VIRAL VACCINES;

ADENOVIRIDAE; ALEUTIAN MINK DISEASE PARVOVIRUS (STRAIN G); ANIMALIA; EBOLA VIRUS; MACACA; PRIMATES; VECTORS;

EID: 0042739176     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature01876     Document Type: Article

References (17)

1. Sullivan, N. L. Sanchez, A., Rollin P. E., Yang, Z.-Y. & Nabel, G. J. Development of a preventive vaccine for Ebola virus infection in primates. Nature 408, 605-609 (2000).
2. Sanchez, A. et al. Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J. Virol. 72, 6442-6447 (1998).
3. Yang, Z.-Y. et al. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nature Med. 6, 886-889 (2000).
4. Volchkov, V. E. et al. Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science 291, 1965-1969 (2001).
5. Chan, S. Y., Ma, M. C. & Goldsmith, M. A. Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J. Gen. Virol. 81, 2155-2159 (2000).
6. Takada, A. et al. Downregulation of β1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology 278, 20-26 (2000).
7. Xu, L. et al. Immunization for Ebola virus infection. Nature Med. 4, 37-42 (1998).
8. Jahrling, P. B. et al. Evaluation of immune globulin and recombinant interferon-α2b for treatment of experimental Ebola virus infections. J. Infect. Dis. 179, S224-S234 (1999).
9. Parren, P. W., Geisbert, T. W., Maruyama, T., Jahrling, P. B. & Burton D. R. Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody. J. Virol. 76, 6408-6412 (2002).
10. Gupta, M., Mahanty, S., Bray, M., Ahmed, R. & Rollin, P. E. Passive transfer of antibodies protects immunocompetent and immunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication. J. Virol. 75, 4649-4654 (2001).
11. Wilson, J. A. & Hart, M. K. Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein. J. Virol. 75, 2660-2664 (2001).
12. World Health Organization. Disease Outbreaks. Ebola Haemorrhagic Fever (http://www.who.int disease-outbreak-news/disease/A98.4.htm) (2003).
13. Walsh, P. D. et al. Catastrophic ape decline in western equatorial Africa. Nature 422, 611-614 (2003).
14. Aoki, K., Barker, C., Damhinne, X., Imperiale, M. J. & Nabel, G. J. Efficient generation of recombinant adenoviral vectors by Cre-lox recombination in vitro. Mol. Med. 5, 224-231 (1999).
15. Ohno, T. et al. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 265, 781-784 (1994).
16. Ksiazek, T. G. et al. Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J. Clin. Microbiol. 30, 947-950 (1992).
17. Jahrling, P. B. et al. Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. Arch. Virol. Suppl. 11, 135-140 (1996).